(Q30858718)

18 August 2017

Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia (English)

1 reference

18 August 2017

1 reference

10

1 reference

PubMed publication ID

27 June 2017

Grazia Palomba

9

0 references

Marina Pisano

object named as

Marina Pisano

8

0 references

author name string

Mario Budroni

1

1 reference

18 August 2017

Rosaria Cesaraccio

2

1 reference

18 August 2017

Vincenzo Coviello

3

1 reference

18 August 2017

Ornelia Sechi

4

1 reference

18 August 2017

Daniela Pirino

5

1 reference

18 August 2017

Antonio Cossu

6

1 reference

18 August 2017

Francesco Tanda

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

20 February 2009

1 reference

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

62

1 reference

Creative Commons Attribution 2.0 Generic

18 August 2017

start time

20 February 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Risk factors for the incidence of breast cancer: do they affect survival from the disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Screening for hereditary breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Breast cancer prognostication and prediction: are we making progress?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Origin and distribution of the BRCA2-8765delAG mutation in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Histopathology of BRCA1- and BRCA2-associated breast cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Survival and prognostic factors in BRCA1-associated breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Gene expression profiling predicts clinical outcome of breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Cancer survival corrected for heterogeneity in patient withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Age adjustment of cancer survival rates: methods, point estimates and standard errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Survival and recurrence after breast cancer in BRCA1/2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Spectrum and prevalence ofBRCA1 andBRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19232099

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19232099

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19232099

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-9-62

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

19232099

1 reference